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recurrence in cervical cancer. Weighted PET parameters 
were less sensitive to the choice of threshold than standard 
parameters computed through hard-thresholding, all tested 
threshold TLG and MTV parameters becoming statistically 
predictive. 
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Purpose or Objective: Quantification of vasculature is 
frequently performed by dynamic contrast enhanced CT 
(DCE-CT) or MRI imaging. However, there are some 
limitations to this technique: DCE-CT requires a detailed 
kinetic fitting procedure, a prolonged acquisition time with 
increased dose to the patient, has a limited FOV and is not 
easy to implement in clinical routine. Dual Energy CT is an 
evolving field in CT image analysis that allows quantification 
of contrast material uptake using a single acquisition, making 
it easily implementable in a clinical workflow. Therefore we 
investigated the correlation between the DCE-CT derived 
vasculature parameters, blood flow and blood volume, with 
iodine related attenuation measured on a Dual Energy CT 
acquisition for non-small cell lung cancer patients. 
 
Material and Methods: The same imaging protocol was 
followed for 13 patients on a Dual Energy CT scanner 
(Siemens Definition Flash). The protocol consisted of a Dual 
Energy CT scan (either 80/140kVp or 100/140kVp; 70 ml of 
iodine 300 mg/ml) of the entire thorax and a DCE-CT 
acquisition (65 ml of iodine 300 mg/ml; 33 frames @ 1.5sec 
for a total of 50 sec) in a 13 cm FOV centred around the 
primary tumour. Kinetic analysis was performed using 
commercial software (Siemens VPCT body) allowing the 
assessment of blood flow (unit: ml/100ml/min) and blood 
volume (unit: ml/100ml) in every voxel. Dual Energy CT 
images were analysed using in-house developed software for 
iodine contrast quantification. Iodine related attenuation was 
calculated by subtracting the Hounsfield units of the CT scan 
acquired at high energy from the scan acquired at low 
energy. A comparison was performed on 1) the entire tumour 
and 2) on a sub-volume level, defined by the upper 50% of 
the volume-of-interest. Correlation on tumour level was 
assessed by the Pearson correlation coefficient; overlap of 
sub-volumes with a DICE coefficient. 
 
Results: There was a significant positive correlation between 
average contrast enhancement on Dual Energy CT and blood 
flow (r=0.615, p=0.025) and blood volume (average r=0.742, 
p=0.004) on a patient (i.e. tumour) level. Furthermore, the 
volumes defined by the highest 50% contrast enhanced 
uptake and 50% elevated perfusion coincided well (see 
Figure), with DICE scores of 0.72±0.10 (range 0.58-0.87) and 
0.71±0.13 (range 0.50-0.91), for the blood flow and volume, 
respectively. 
 
 
 
Figure: Example of a patient showing a heterogeneous 
vasculature; the DICE coefficients for this patient, between 
the Dual Energy CT iodine enhancement and DCE-CT blood 
flow and blood volume, were respectively 0.87 and 0.91. 
 
Conclusion: We observed high agreement between Dual 
Energy CT derived iodine enhancement and DCE-CT derived 
kinetic parameters, both on a tumour and sub-volume level. 
This may allow wider implementation of vasculature imaging 
of tumours using the simplified Dual Energy CT acquisition 
protocol. 
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Purpose or Objective: Patients with lung cancer given 
external radiotherapy are at risk of radiation induced lung 
toxicity (RILT). In many studies, mean density changes from 
CT (in Hounsfield units) have been used as a surrogate for 
radiation-induced alterations in the lung. However, a 
combination of mean density changes from CT scans with 
corresponding standard deviations has been shown to be a 
more sensitive method. In the current work, we explore 
whether such a combined approach is feasible for 18F-FDG 
PET data as well. 
 
Material and Methods: 13 patients with advanced non-small 
cell lung cancer, participating in a phase II trial on combined 
radiation and erlotinib therapy, were included. The patients 
were examined by 18F-FDG-PET/CT at three sessions; prior 
to, one week into, and six weeks after fractionated 
radiotherapy (3 Gy × 10). For each patient, lung was 
delineated in the planning CT images. The RT dose matrix 
was co-registered with the PET image series. For each PET 
image series, mean (μ) and standard deviation (σ) map were 
calculated based on cubes in the lung (3×3×3 voxels) and 
were further used to quantify local structure (S). The spread 
in μ and σ was characterized by a local covariance ellipse (in 
pre-therapy PET series) in a sub-volume of 3×3×3 cubes. The 
distance of individual cube values to the origin of the ellipse 
is then calculated using Mahalanobis distance method to form 
S maps. ΔS and Δμ maps are derived by subtracting pre-
therapy maps from maps of mid- and post-therapy. A 
detection threshold was calculated based on three patients 
with two sets of pre-therapy PET scans who were not 
included in the study. 
 
Results: The structure difference maps (ΔS) identified new 
areas of interest in the lungs of individual patients compared 
to the mean difference maps (Δμ) (Figure 1 A). On a 
population level, both ΔS and Δm were significantly different 
(P<0.05) from the respective threshold level, irrespective of 
dose (Figure 1 B). The inter-patient relative variation in ΔS 
and Δμ were 57% and 88%, respectively, indicating that the 
ΔS approach yielded less heterogeneous results. 18F-FDG 
dose response was analyzed up to total dose of 15 Gy by first 
order linear regression. The relative slopes of the regression 
lines were 0.036, 0.018, 0.052, and 0.061 for Δμ (mid-pre), 
ΔS (mid-pre), Δμ(mid-pre), and ΔS (post-pre), respectively. A 
significant dose response was only seen for the ΔS taken 
between post and pre-therapy PET. 
